Hikma Pharmaceuticals Celebrates its Global Volunteering Day

Amman, 19 April 2012 – Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, held its annual volunteering day yesterday, continuing a long tradition of encouraging its staff to participate in community projects. A Hikma Global initiative, the volunteering day allows staff to take part in important and rewarding activities that help those less fortunate.

Press Release Responsibility 19 April 2012

This year, employees of Hikma Jordan visited the SOS Children's Villages, to take part in renovation activities that included painting doors and maintaining the garden. Children from the SOS Villages were also accompanied by Hikma volunteers on an exciting trip to the Children's Museum in Amman, where they played with the exhibits and carried out some scientific experiments. This was a fantastic opportunity for the children to enjoy themselves in a highly educational environment, discovering more about the world around them through fun activities. In addition, an educational lecture was held at Hikma's premises for its employees on cognitive distortions and their impact on personal wellbeing, reinforcing Hikma's commitment to ensuring that its staff is well-informed on the latest healthcare issues.

Commenting on the volunteering day activities, Hana Ramadan, Director of Corporate Communications at Hikma Pharmaceuticals, said: "We are celebrating our fifth annual volunteering day alongside Hikma colleagues in Saudi Arabia, Egypt, Lebanon, Tunisia, Algeria, Portugal, Germany, Italy and the United States. Our objective today is to create bridges to the local community, supporting them in ways that are constructive and really make a difference."

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.